An interesting article popped up this week in PharmaLive’s Product Marketing Weekly. Highlighting a new wave of external partners defining Pharma 3.0, the article focused on the effects of downsizing in the industry, and how pharmaceutical companies, now more than ever, are turning to external partners for non-core business functions.
At Thought Leader Select, we have implemented key opinion leader identification and profiling for dozens of the world’s leading pharmaceutical and biotechnology companies. Our research fuels superior KOL deployment across the array of applications in which companies use their thought leaders. We have proven ourselves to be a key partner in the development and marketing of new drug therapies since our founding.
Check out the PharmaLive article here: http://pharmalive.com/news/index.cfm?articleID=684532&categoryid=43&newsletter=1
